Literature DB >> 15446804

Modelling of post-irradiation accelerated repopulation in squamous cell carcinomas.

L Marcu1, T van Doorn, I Olver.   

Abstract

The mechanisms postulated to be responsible for the accelerated repopulation of squamous cell carcinomas during radiotherapy are the loss of asymmetry of stem cell division, acceleration of stem cell division, abortive division and/or recruitment of the non-cycling cell with proliferative capacity. Although accelerated repopulation was observed with recruitment and accelerated cell cycles, it was not sufficient to cause an observable change to the survival curve. However, modelling the loss of asymmetry in stem cell division has reshaped the curve with a 'growth' shoulder. Cell recruitment was not found to be a major contributor to accelerated tumour repopulation. A more significant contribution was provided through the multiplication of surviving tumour stem cells during radiotherapy, by reducing their cell cycle time, and due to loss of asymmetry of stem cell division.

Entities:  

Mesh:

Year:  2004        PMID: 15446804     DOI: 10.1088/0031-9155/49/16/021

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  17 in total

1.  Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.

Authors:  W M Harriss-Phillips; E Bezak; E K Yeoh
Journal:  Br J Radiol       Date:  2011-10       Impact factor: 3.039

2.  Influence of stem-cell cycle time on accelerated re-population during radiotherapy in head and neck cancer.

Authors:  L G Marcu; E Bezak
Journal:  Cell Prolif       Date:  2012-07-07       Impact factor: 6.831

3.  Onset time of tumor repopulation for cervical cancer: first evidence from clinical data.

Authors:  Zhibin Huang; Nina A Mayr; Mingcheng Gao; Simon S Lo; Jian Z Wang; Guang Jia; William T C Yuh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-02       Impact factor: 7.038

Review 4.  Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy.

Authors:  Mary A Zimmerman; Qian Huang; Fang Li; Xinjiang Liu; Chuan-Yuan Li
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

5.  Tumour repopulation and the role of abortive division in squamous cell carcinomas during chemotherapy.

Authors:  L G Marcu
Journal:  Cell Prolif       Date:  2014-05-13       Impact factor: 6.831

6.  Quantification of the effect of treatment duration on local-regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.

Authors:  Mary E Platek; Susan A McCloskey; Myra Cruz; Mark S Burke; Mary E Reid; Gregory E Wilding; Nestor R Rigual; Saurin R Popat; Thom R Loree; Vishal Gupta; Graham W Warren; Maureen Sullivan; Wesley L Hicks; Anurag K Singh
Journal:  Head Neck       Date:  2012-05-22       Impact factor: 3.147

7.  Estimate of the accelerated proliferation by protein tyrosine phosphatase (PTEN) over expression in postoperative radiotherapy of head and neck squamous cell carcinoma.

Authors:  P Pedicini; A Fiorentino; G Improta; A Nappi; M Salvatore; G Storto
Journal:  Clin Transl Oncol       Date:  2013-03-05       Impact factor: 3.405

8.  In silico study of the impact of cancer stem cell dynamics and radiobiological hypoxia on tumour response to hyperfractionated radiotherapy.

Authors:  L G Marcu; D Marcu; S M Filip
Journal:  Cell Prolif       Date:  2016-04-15       Impact factor: 6.831

9.  Radiobiological modeling of interplay between accelerated repopulation and altered fractionation schedules in head and neck cancer.

Authors:  Loredana G Marcu; Eva Bezak
Journal:  J Med Phys       Date:  2009-10

10.  Adjuvant Postoperative Radiotherapy with or without Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: The Importance of Patient Selection for the Postoperative Chemoradiotherapy.

Authors:  Jong Hoon Lee; Jin Ho Song; Sang Nam Lee; Jin Hyoung Kang; Min Sik Kim; Dong Il Sun; Yeon-Sil Kim
Journal:  Cancer Res Treat       Date:  2013-03-31       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.